PLOD1 and breast cancer: Clinical data from BC patients were obtained from TCGA database, and information on survival revealed that patients with high PLOD1 expression had a significantly poorer prognosis compared with patients with low expression (disease‐free survival: P = 0.0204; overall survival: P = 0.000174; Fig. 2B).